Log In
Print
BCIQ
Print
Print this Print this
 

LOXO-101

  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionNeurotrophic tyrosine kinase receptor 1 (NTRK1; TrkA) inhibitor
Molecular Target Neurotrophic tyrosine kinase receptor 1 (NTRK1) (TrkA)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner

Loxo Oncology Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today